Kilo Code, one of the most popular open-source coding agents, today announced it has been named a coolest vendor innovation in the 2026 Gartner® Coolest Vendor Innovations in AI Coding Agents. 1 "In ...

A college student in Michigan received a threatening response during a chat with Google's AI chatbot Gemini. In a back-and-forth conversation about the challenges and solutions for aging adults, ...

It’s safe to say Apple has taken its sweet time bringing its AI ambitions to fruition. After debuting Apple Intelligence two years ago, Apple unveiled a whole new Siri at WWDC 2026 last week. Dubbed ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. Join the Tom's Guide ...

Most of my time as a writer is spent bemoaning the current state of college football or breaking down obscure scenes from "The Sopranos" that no one has thought about for 20 years, but occasionally I ...

Ari was not just a stuffed polar bear. He was the constant companion to Kathy’s grandson Julian — sitting with him at restaurants, traveling by his side on family trips and occupying a special spot in ...

At WWDC 2026, Apple announced Siri AI and a new wave of Apple Intelligence features powered by Gemini at the underlying level. Apple today said it “embarked on a deep collaboration with Google, ...

Artificial intelligence is reshaping economies, societies, and daily life. Its opportunities are real. So are its risks. No country can address either alone. The AI Dialogue exists to ensure that ...

Generative AI can help you find information. If you're bored with traditional search, check out the top AI search engines we've tried. I’ve been writing about consumer technology and video games for ...

If you're on the software developer side of the internet, you've probably heard the term "vibe coding" recently. Andrej Karpathy coined this phrase to reference a style of coding where artificial ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...